Dr. Jochen Mueller-Ibeler is an accomplished professional in the field of chemistry and biotechnology, currently serving as a Board Member at BigOmics Analytics since February 2022 and involved with the Eppendorf Innovation Company (EpIC) since April 2021. Previously, Dr. Mueller-Ibeler held various key positions at Eppendorf Group from July 2004 to October 2020, including Head of Business Unit Automation and Executive Director Field Applications. Prior experience includes roles as Project Manager at Nanogen Recognomics GmbH and Project & Laboratory Manager at Sanofi, along with a tenure as Principle Scientist (Post-Doc) at Sanofi. Dr. Mueller-Ibeler earned a Ph.D. in Chemistry from the Max Planck Society and a Diplom in Chemistry from Ruhr University Bochum.